ISRCTN15812702已完成未知
Diarrhoea management through the development of nanoparticle-based rotavirus diarrhoea diagnostic kits and viral diarrhoea awareness
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 186
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Children (aged 0 to 60 months)
- •2. Acute diarrheal episode (diarrhoea will be defined as three or more loose stools in the last 24 hours with or without other symptoms such as fever, vomiting or dehydration and the onset must be within the last 7 days)
- •1. Healthy children coming to the same hospital/health centre for routine immunization and not presenting with gastroenteritis symptoms for the past 14 days
排除标准
- •1. Children who do not have diarrhoea
- •2. Children older than 5 years
- •3. Parents or guardians do not give formal consent to participate in the study
- •1. Sick children
- •2. Children older than 5 years
- •3. Parents or guardians do not give formal consent to participate in the study
研究者
相似试验
尚未招募
不适用
Management of diarrhoea in tube-fed patients by providing formula low in poorly absorbed sugars (Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols or FODMAPs)Enteral nutrition-associated diarrhoeaDiet and Nutrition - Other diet and nutrition disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612000644864Monash University100
进行中（未招募）
1 期
Treatment of Diarrhea-predominant Irritable Bowel Syndrome with LACTEOL 340 mg : a pilot study evaluating safety and efficacyDiarrhea-predominant Irritable Bowel SyndromeMedDRA version: 12.1Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeEUCTR2009-017874-20-FRAXCAN PHARMA SAS60
进行中（未招募）
不适用
Treatment of Diarrhea-predominant Irritable Bowel Syndrome with LACTEOL 340 mg : a pilot study evaluating safety and efficacyDiarrhea-predominant Irritable Bowel SyndromeMedDRA version: 12.1Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeEUCTR2009-017874-20-DEAXCAN PHARMA INC60
招募中
不适用
Etiology, Epidemiology and Treatment of Diarrhea and Enterocolitis in Hemato-oncological High Risk Patients (EpiDi)Haematologic malignancyDRKS00000111niklinik Köln400
招募中
1 期
Study on the treatment of diarrhea-predominant irritable bowel syndrome with Xifenghuashi Granules through changes in intestinal floraITMCTR2100004795Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine